论文部分内容阅读
目的观察药物治疗急性支气管肺炎患儿的临床治疗效果。方法选取云南省金平县人民医院急性支气管肺炎患儿188例,使用抽签方式将其分成2组,实验组与对照组(n=94),2组患儿均使用化痰、止咳、抗炎等常规药物进行治疗,同时注意观察患儿的卫生、睡眠、饮食情况。对照组在常规治疗的基础上使用利巴韦林口服颗粒,实验组在常规治疗的基础上加入四季抗毒合剂,比较观察2组患儿的药物治疗效果与不良反应。结果 2组患儿经过7d的药物治疗后,实验组总有效率为94.7%,明显高于对照组的72.3%;实验组中有6例患儿出现不良反应,占总数的8.51%,对照组中有27例患儿出现不良反应,占总数的28.72%,2组患儿治疗效果与不良反应发生率比较,差异均具有统计学意义(P<0.05)。结论在治疗急性支气管肺炎患儿时,使用四季抗毒合剂,不仅具有良好的抗病毒、抗菌作用,还能减小不良反应,降低患儿痛苦,可以作为治疗急性支气管肺炎的首选药物。
Objective To observe the clinical effect of drug treatment in children with acute bronchopneumonia. Methods 188 children with acute bronchial pneumonia in Jinping People’s Hospital of Yunnan Province were selected and divided into two groups by random sampling. The experimental group and the control group (n = 94), both groups were treated with phlegm, cough and anti-inflammatory Conventional drugs for treatment, while observing children’s health, sleep, diet. The control group received ribavirin oral granules on the basis of routine treatment. The experimental group was treated with Shiji Anti-toxic Mixture on the basis of routine treatment, and the drug treatment effects and adverse reactions of the two groups were compared. Results After 7 days of drug treatment, the total effective rate of the experimental group was 94.7%, which was significantly higher than that of the control group (72.3%). Six of the experimental group showed adverse reactions, accounting for 8.51% of the total. In the control group There were 27 cases of children with adverse reactions, accounting for 28.72% of the total, two groups of children with treatment and adverse reactions, the differences were statistically significant (P <0.05). Conclusion In the treatment of children with acute bronchopneumonia, the four seasons antitoxic mixture not only has good anti-virus and antibacterial activity, but also can reduce adverse reactions, reduce the pain of children, and can be used as the first choice for the treatment of acute bronchopneumonia.